Literature DB >> 2112790

The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumors.

K Saito1, M Nagashima, M Iwata, H Hamada, K Sumiyoshi, Y Takada, A Takada.   

Abstract

The concentrations of tissue plasminogen activator (t-PA) and urokinase (UK) were measured in the plasma of patients with benign or malignant ovarian and uterine tumors. Plasma levels of t-PA were higher in patients with malignant ovarian and uterine tumors than in patients with benign tumors. Plasma UK levels were, however, not different between patients with ovarian and uterine tumors (benign or malignant) and normal persons. The concentrations of t-PA and UK of tissues of uterine myoma were lower than those in normal uterine muscular layer. UK levels of tissues of endometrial and cervical cancers were significantly higher than those in normal endometrium and uterine cervix, whereas t-PA levels were not different between these tumors compared with those in normal uterine tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112790     DOI: 10.1016/0049-3848(90)90207-s

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Authors:  Lakshmi Venkatraman; Huipeng Li; C Forbes Dewey; Jacob K White; Sourav S Bhowmick; Hanry Yu; Lisa Tucker-Kellogg
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

2.  Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer.

Authors:  H Ito; Y Yonemura; H Fujita; K Tsuchihara; T Kawamura; N Nojima; T Fujimura; H Nose; Y Endo; T Sasaki
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

3.  Expression and localization of urokinase-type plasminogen activator in human spinal column tumors.

Authors:  Z L Gokaslan; S K Chintala; J E York; V Boyapati; S Jasti; R Sawaya; G Fuller; D M Wildrick; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

4.  Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.

Authors:  Lakshmi Venkatraman; Ser-Mien Chia; Balakrishnan Chakrapani Narmada; Jacob K White; Sourav S Bhowmick; C Forbes Dewey; Peter T So; Lisa Tucker-Kellogg; Hanry Yu
Journal:  Biophys J       Date:  2012-09-05       Impact factor: 4.033

Review 5.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

6.  Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

Authors:  D Foucré; C Bouchet; K Hacène; N Pourreau-Schneider; A Gentile; P M Martin; A Desplaces; J Oglobine
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.